Larimar Therapeutics
Theresa Candido is a skilled Quality Systems Specialist with extensive experience in managing GXP document lifecycles and document management systems. Currently serving as a Sr. Quality Systems Specialist at Larimar Therapeutics Inc. since February 2025, Theresa has previously held roles at organizations such as Imvax, Neuronetics, Adaptimmune, Janssen Diagnostics, Johnson Matthey Fine Chemicals, Windtree Therapeutics, and Centocor, where responsibilities included overseeing document approval processes, training users on electronic document management systems, and ensuring compliance with quality management standards. Theresa's educational background includes studies at Delaware County Community College from 1999 to 2000.
This person is not in any teams
This person is not in any offices
Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease.